Clinicopathological features | AC | Cancer patients |
---|---|---|
Number | 136 | 323 |
Age median (range) | 57 (48–66) | 68 (27–93) |
Lung cancer | ||
Number | 102 | |
Age median (range) | 66 (45–89) | |
Histological type | n.a. | |
Non-small cell lung carcinoma (NSCLC) | ||
Adenocarcinoma | 42 | |
Squamous cell carcinoma | 43 | |
Large cell carcinoma | 1 | |
Small cell lung carcinoma (SCLC) | 16 | |
Primary tumour (T)a | n.a. | |
T1 | 12 | |
T2/T3/T4 | 82 | |
Regional lymph node (N)b | n.a. | |
N0 | 25 | |
N+ | 72 | |
Distant metastasis (M) | n.a. | |
M0 | 47 | |
M+ | 55 | |
Clinical stage | n.a. | |
I/II | 17 | |
III/IV | 85 | |
Prostate cancer | ||
Number | 121 | |
Age median (range) | 71 (52–88) | |
Histological type | n.a. | |
Adenocarcinoma | 121 | |
Primary tumour (T)c | n.a. | |
T1/T2 | 104 | |
T3 | 16 | |
Regional lymph node (N) | n.a. | |
N0 | 119 | |
N+ | 2 | |
Distant metastasis (M) | n.a. | |
M0 | 116 | |
M+ | 5 | |
Grade group | n.a. | |
1 | 59 | |
2 | 38 | |
3/4/5 | 24 | |
Serum PSA levels (ng/mL) | n.a. | |
< 10 | 71 | |
10–20 | 27 | |
> 20 | 23 | |
Clinical stage | n.a. | |
I | 31 | |
II | 55 | |
III/IV | 35 | |
Colorectal cancer | ||
Number | 100 | |
Age median (range) | 66 (27–93) | |
Histological Type | n.a. | |
Adenocarcinoma (all subtypes) | 99 | |
Squamous cell carcinoma | 1 | |
Tumour location | n.a. | |
Proximal colon | 23 | |
Distal colon | 36 | |
Rectum | 41 | |
Primary tumour (T)d | n.a. | |
T1/T2 | 26 | |
T3/T4 | 72 | |
Regional lymph node (N)e | n.a. | |
N0 | 40 | |
N+ | 57 | |
Distant metastasis (M) | n.a. | |
M0 | 82 | |
M+ | 18 | |
Clinical stage | n.a. | |
I/II | 39 | |
III/IV | 61 |